Call for Abstract

17th World Congress on Stem Cell Research, will be organized around the theme “Exploring the Potency of Stem Cells for Healing and Innovation”

STEM CELL CONGRESS 2024 is comprised of 16 tracks and 0 sessions designed to offer comprehensive sessions that address current issues in STEM CELL CONGRESS 2024.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

Stem cell and regenerative drugs encompass a diverse range of therapeutic approaches aimed at harnessing the regenerative potential of stem cells to treat diseases and injuries. These drugs may involve the use of stem cells themselves, derived from various sources such as bone marrow, adipose tissue, or embryonic sources, or they may consist of molecules and compounds that stimulate endogenous stem cells within the body. The goal of these therapies is to promote tissue repair, regeneration, and restoration of function in damaged or diseased tissues and organs.

Cell and genetic therapy represents a cutting-edge approach to treating diseases by harnessing the power of cells and genetic material to target underlying causes. Cell therapy involves the transplantation or manipulation of cells, often stem cells, to repair, replace, or regenerate damaged tissues or organs. These cells can be sourced from various origins, including the patient's own body, donors, or cultured in a laboratory.

Bone marrow transplantation is particularly effective in treating diseases such as leukemia, lymphoma, and multiple myeloma, where the patient's bone marrow is affected by cancerous or abnormal cells. By replacing the diseased marrow with healthy stem cells, the procedure aims to restore normal blood cell production and function.

Stem cells play a pivotal role in drug discovery, offering a versatile platform for modeling diseases, screening potential therapeutics, and understanding drug mechanisms of action. One key application of stem cells in drug discovery is disease modeling. By differentiating stem cells into specific cell types affected by diseases, researchers can create in vitro models that closely mimic disease pathology. Stem cells are also used in high-throughput drug screening assays to evaluate the efficacy and safety of candidate drugs.

Stem cell apoptosis, or programmed cell death, plays a crucial role in regulating the balance between cell proliferation, differentiation, and tissue homeostasis within stem cell populations. Apoptosis is a natural process by which cells undergo self-destruction in response to various internal and external signals. In the context of stem cells, apoptosis serves several important functions:

  • Maintaining Stem Cell Pool
  • Controlling Differentiation
  • Tissue Repair and Regeneration
  • Preventing Tumorigenesis

Neurodegenerative diseases are a group of disorders characterized by progressive dysfunction and loss of neurons in the central nervous system (CNS) or peripheral nervous system (PNS). These diseases result in the gradual deterioration of cognitive function, motor skills, and/or behavior, leading to significant disability and impairment of quality of life. Common neurodegenerative diseases include Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS), among others. The causes of neurodegenerative diseases are multifactorial and often involve a complex interplay of genetic, environmental, and lifestyle factors.

The multidisciplinary area of tissue engineering applies biology, engineering, and medicine concepts to develop biological replacements that can preserve or enhance tissue function. Biological scaffolding, growth factors, and cells must be developed to repair injured tissues and organs. Tissue engineering seeks to transform healthcare by delivering individualized and efficient therapies using the body's regenerative mechanisms, cutting-edge materials, and technologies.

Dental stem cells are a promising frontier in regenerative medicine, offering potential treatments for a variety of conditions. Found within teeth, these stem cells can differentiate into various cell types, including those found in dental tissues like dentin, pulp, and periodontal ligament. Their accessibility and relative abundance make them an attractive source for therapeutic applications.

Bio-banking of stem cells involves the collection, processing, and storage of stem cells for future therapeutic use or research purposes. Stem cells are preserved under controlled conditions to maintain their viability and functionality over extended periods. These biobanks serve as valuable repositories of stem cell resources, facilitating research, clinical trials, and the development of regenerative therapies. By storing stem cells, biobanks offer a source of personalized medicine, allowing individuals to access their stem cells for potential future treatments. Bio-banking stem cells play a crucial role in advancing regenerative medicine, providing a foundation for ground-breaking discoveries and medical interventions to address a wide range of diseases and conditions.

Clinical methods refer to the techniques, procedures, and approaches used by healthcare professionals to assess, diagnose, treat, and monitor patients' health conditions. These methods encompass a wide range of tools and practices employed across various medical specialties and disciplines.

Clinical methods may include:

·         Medical History

·         Physical Examination

·         Diagnostic Tests

·         Clinical Assessment Tools

·         Clinical Procedures

·         Clinical Observation

·         Patient Counselling and Education

Translational research in stem cell science bridges the gap between basic laboratory discoveries and their application in clinical settings, with the ultimate goal of improving patient care and outcomes. It involves translating findings from stem cell research into tangible therapeutic interventions, diagnostic tools, and medical technologies that can be used to diagnose, treat, and prevent diseases.

Translational stem cell research encompasses several key stages:

  • Discovery and Preclinical Research
  • Clinical Trials
  • Regulatory Approval and Clinical Implementation
  • Clinical Application and Patient Care
  • Post-Market Surveillance and Long-Term Monitoring

Stem cell embryology is a field of study focused on understanding the developmental processes that govern the formation of tissues and organs during embryonic development, particularly concerning the role of stem cells. Embryonic stem cells (ESCs) are pluripotent cells derived from the inner cell mass of early-stage embryos. They have the remarkable ability to differentiate into all cell types of the body, making them valuable tools for studying embryonic development and regenerative medicine applications.

 

Stem cells offer a powerful platform for modeling human diseases in the laboratory, providing researchers with valuable tools to study disease mechanisms, identify novel therapeutic targets, and develop more effective treatments. By reprogramming adult cells into induced pluripotent stem cells (iPSCs), scientists can generate patient-specific cell lines that carry the genetic mutations associated with a particular disease. These iPSCs can then be differentiated into disease-relevant cell types, such as neurons for neurological disorders, cardiomyocytes for heart diseases, or hepatocytes for liver disorders. This approach allows researchers to recapitulate key aspects of disease pathology in a controlled, laboratory setting.

Stem cell-based disease models enable researchers to:

  • Study Disease Mechanisms
  • Screen for Drug Candidates
  • Personalized Medicine
  • Disease Monitoring and Biomarker Discovery

Stem cell therapy is a promising approach in regenerative medicine that harnesses the unique properties of stem cells to treat a variety of diseases, injuries, and degenerative conditions. Stem cells have the remarkable ability to differentiate into various cell types and tissues, repair damaged cells, and modulate the immune response, making them attractive candidates for therapeutic interventions. Stem cell therapy holds promise for treating a wide range of conditions, including neurological disorders (such as Parkinson's disease and spinal cord injury), cardiovascular diseases, orthopedic injuries, autoimmune diseases, and certain types of cancer.

 

Stem cell animal applications encompass a variety of innovative approaches aimed at improving animal health, welfare, and production. These applications leverage the unique properties of stem cells to address various challenges in veterinary medicine, agriculture, and conservation. In veterinary medicine, stem cell therapy is being explored as a treatment for a range of conditions in companion animals, such as osteoarthritis, tendon and ligament injuries, and certain neurological disorders. By harnessing the regenerative potential of stem cells, veterinarians aim to enhance healing and improve the quality of life for animals. In agriculture, stem cell technologies offer opportunities to enhance livestock breeding programs, improve animal productivity, and develop disease-resistant breeds.

Stem cell therapy holds promise for treating cardiovascular diseases, which remain a leading cause of morbidity and mortality worldwide. Stem cells have the potential to repair damaged heart tissue, improve cardiac function, and promote vascular regeneration, offering new avenues for addressing the limitations of current treatments for cardiovascular conditions.

Stem cell therapy in cardiovascular disease aims to achieve several therapeutic objectives, including:

  • Cardio-myocyte Regeneration
  • Angiogenesis and Vasculogenesis
  • Anti-inflammatory and Immunomodulatory Effects
  • Paracrine Signalling